文献速递头颈外科

头颈癌患者治疗前肥胖与肌肉减少症和生存之间的关联

Association between pretreatment obesity, sarcopenia, and survival in patients with head and neck cancer.
PubMed 文献 · Head Neck · 2018-12-23

该回顾性分析纳入441例在Montefiore医疗中心(纽约)接受治疗的头颈部鳞状细胞癌患者,按治疗前BMI分组并校正合并症后评估生存差异,其中113例通过治疗前腹部CT评估肌肉减少症。超重/肥胖患者总生存显著优于正常体重患者(HR=0.4,95%CI:0.3-0.6);肌肉减少症患者生存显著更差(HR=2.1,95%CI:1.1-3.9),该关联在超重/肥胖患者中最强。作者认为除BMI外,肌肉减少症评估对HNSCC患者具有重要性。

要点

  • 治疗前55%的HNSCC患者为超重或肥胖。
  • 超重/肥胖患者总生存优于正常体重患者(HR=0.4,95%CI:0.3-0.6),独立于合并症。
  • 肌肉减少症患者生存更差(HR=2.1,95%CI:1.1-3.9),超重/肥胖者中关联最强。

核心结论

  • 作者认为其数据支持在HNSCC患者中除BMI外还应评估肌肉减少症。

研究设计与样本

  • 回顾性分析纳入441例在Montefiore医疗中心(纽约)接受治疗的正常体重、超重和肥胖HNSCC患者,按治疗前BMI分组并校正心血管疾病和糖尿病等合并症后评估生存差异。
  • 其中113例患者通过治疗前腹部CT评估肌肉减少症。

主要发现

  • 治疗前55%的HNSCC患者为超重或肥胖。
  • 超重/肥胖患者总生存显著优于正常体重患者(HR=0.4,95%CI:0.3-0.6),独立于合并症。
  • 肌肉减少症患者生存显著差于非肌肉减少症患者(HR=2.1,95%CI:1.1-3.9),该关联在超重/肥胖患者中最强。

临床怎么用

  • 作者认为在HNSCC患者中除BMI外,肌肉减少症评估具有重要性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Body mass index (BMI), sarcopenia, and obesity-related comorbidities have been associated with head and neck squamous cell carcinoma (HNSCC) progression. METHODS: We conducted a retrospective analysis of 441 normal-weight, overweight, and obese HNSCC patients treated at Montefiore Medical Center (New York). Patients were grouped by BMI prior to treatment and assessed for differences in survival adjusting for comorbid conditions (cardiovascular disease and diabetes). Evidence of sarcopenia was also assessed using pretreatment abdominal CT scans in a subset of 113 patients. RESULTS: Prior to treatment, 55% of HNSCC patients were overweight or obese. Overweight/obese patients had significantly better overall survival (hazard ratio [HR] = 0.4, 95% CI: 0.3-0.6) compared to normal-weight patients, independent of comorbid conditions. Patients with sarcopenia had significantly poorer survival (HR = 2.1, 95% CI: 1.1-3.9) compared to non-sarcopenic patients, with the strongest association seen among overweight/obese patients. CONCLUSION: Our data support the importance of sarcopenia assessment, in addition to BMI, among patients with HNSCC.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Fattouh M, Chang GY, Ow TJ, et al. Association between pretreatment obesity, sarcopenia, and survival in patients with head and neck cancer. Head Neck. 2018. PMID: 30582237. doi:10.1002/hed.25420

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。